Improved Prediction Of Prostate Cancer Recurrence Through Systems Pathology
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Men's health; Clinical Trials / Drug Trials
Article Date: 15 Jul 2007 - 0:00 PDT
'Improved Prediction Of Prostate Cancer Recurrence Through Systems Pathology'
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
UroToday.com- Dr. Cordon-Cardo and collaborators report development of systems pathology that incorporates clinical and pathologic variables to predict prostate cancer (CaP) recurrence. Their work appears in the online version of the Journal of Clinical Investigation.
Systems pathology is a methodology that uses object-oriented image analysis, pattern recognition, and quantitative biomarker multiplexing that are analyzed by supervised machine learning algorithms. An initial study based upon 323 patients identified that high levels of androgen receptor as identified by immunohistochemical staining were correlated with a reduced time to PSA recurrence. This was then combined with the pathologic variables of biopsy Gleason score, seminal vesicle invasion, extracapsular extension, primary radical prostatectomy Gleason score, and preoperative PSA in addition to the texture of epithelial nuclei and cytoplasm in tumor areas for the systems pathology platform.
A validation study was performed in 366 patients but only 61 of these had adequate tissue in the microarrays to be included. PSA recurrence was found in 26 of the 61 men (43%). The model applied to these 61 patients demonstrated a sensitivity of 96% and a specificity of 72% for the detection of PSA recurrence by 5 years post surgery.
The authors comment that this approach provides an aspect of personalized medicine to help decision-making.
Cordon-Cardo C, Kotsianti A, Verbel DA, Teverovskiy M, Capodieci P, Hamann S, Jeffers Y, Clayton M, Elkhettabi F, Khan FM, Sapir M, Bayer-Zubek V, Vengrenyuk Y, Fogarsi S, Saidi O, Reuter VE, Scher HI, Kattan MW, jr. Bianco FJ, Wheeler TM, Ayala GE, Scardino PT, Donovan MJ
J Clin Invest. ePub, June 7, 2007
Doi: 10.1172/JCI31399
Reported by UroToday.com Contributing Editor Christopher P. Evans, M.D
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
26 May. 2012. <http://www.medicalnewstoday.com/releases/76846.php>
APA
http://www.medicalnewstoday.com/releases/76846.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Improved Prediction Of Prostate Cancer Recurrence Through Systems Pathology'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





